Intense efforts are underway to develop vaccines for SARS-CoV-2. Many focus on the spike protein, which helps the virus infiltrate cells by binding the ACE2 receptor. Alternative strategies could block this receptor to prevent viral entry. Studies found SARS-CoV-2 uses ACE2 and TMPRSS2 for entry, and may use CD147 as an additional receptor. RNAscope probes target viral RNA to detect replication and localization in tissues, and can identify ACE2, TMPRSS2, and immune cell markers in infected samples.